AXSOME THERAPEUTICS, INC. Total Assets
AXSOME THERAPEUTICS, INC. (AXSM) had Total Assets of $761.45 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-10
- 2026-06-30: Assets $761.45M.
- 2026-03-31: Assets $713.61M.
- 2025-12-31: Assets $689.80M.
- 2025-09-30: Assets $669.25M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $761.45M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $713.61M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $689.80M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $669.25M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $639.78M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $596.67M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $568.50M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $561.46M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $548.23M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $545.73M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $588.24M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $600.86M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $611.64M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $389.18M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $331.48M 10-K · filed 2024-02-23 | $331.48M 10-K · filed 2023-02-28 |
| 2022-09-30 | $338.96M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $180.56M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $88.56M 10-Q · filed 2022-05-02 | |
| 2021-12-31 | $87.79M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $116.60M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $143.26M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $166.90M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $186.13M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $203.63M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $190.99M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $197.80M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $220.55M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $44.44M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $54.78M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $43.90M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $15.38M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $16.13M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $21.73M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $27.94M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $35.56M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $32.62M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $39.04M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $46.41M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $38.21M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $34.92M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $40.01M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $45.15M 10-Q/A · filed 2016-08-09 | |
| 2015-12-31 | $49.08M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |